流式细胞仪的技术革新与自动化：analytica 2026全景见闻

Core Insights - The 2026 Munich Biochemical Exhibition showcased the latest advancements in flow cytometry, highlighting trends towards high parameterization, automation, and customization in applications [2][14]. Group 1: Key Trends in Flow Cytometry - Flow cytometry is experiencing a paradigm shift with the integration of optical detection, microfluidic control, and artificial intelligence algorithms, reshaping industry standards and application boundaries [14]. - The detection capabilities are expanding from cellular analysis to the nanoscale, with new devices like Beckman Coulter's CytoFLEX nano achieving detection limits of 40-80 nm, addressing the need for detecting exosomes and viral particles [15]. - Automation in laboratories is increasing due to rising labor costs and the demand for large-scale screening, with new products featuring automated sampling systems and AI-driven data analysis [16]. Group 2: Product Highlights - Beckman Coulter's CytoFLEX mosaic 88 offers a dual-mode platform with 88 detection channels, enabling over 40 colors for complex immune profiling [3]. - Sartorius's iQue 5 is a benchmark in high-throughput screening, capable of analyzing 96-well plates in 5 minutes with a sample consumption of only 1μL [4]. - Bio-Techne's Pala system is designed for single-cell sorting with a high cell recovery rate, suitable for precious clinical samples [4]. Group 3: Market Dynamics - The industry is shifting from general-purpose platforms to specialized devices tailored for specific applications, such as high-throughput screening in antibody development and clinical diagnostics [17]. - The integration of automated workflows and validated testing kits is enhancing compliance and operational efficiency in clinical settings [17]. - The flow cytometry technology is penetrating new markets, including environmental monitoring and food safety, indicating a diversification of applications [17]. Group 4: Future Outlook - The innovations presented at the exhibition demonstrate the industry's vitality, with ongoing technological iterations and application expansions driving flow cytometry from research labs to broader clinical and industrial contexts [19].